$7.1MSeries A, 25 February 2026
Series A for brand building, expansion to US, UK and Middle East, and R&D and manufacturing.
- Amount
- $7.1M
- Stage
- Series A
- Announced
- 25 February 2026
- Lead
- Kotak Alternate Asset Managers
- Other investors
- Alkemi Growth Capital
- Use of funds
- Series A for brand building, expansion to US, UK and Middle East, and R&D and manufacturing.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Supplement startup ZeroHarm Sciences nets Rs 65 Cr entrackr.com
Supplement startup ZeroHarm Sciences nets Rs 65 Cr inc42.com